Brief: Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial
06/02/2025 12:49
Feb 6 (Reuters) - Trinity Biotech PLC TRIB.O :
* TRINITY BIOTECH PLC - TO BEGIN FURTHER PRE-PIVOTAL TRIALS
FOR
GLUCOSE MONITORING SYSTEM IN Q1 2025
Source text: ID:nGNX6MckHZ
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM